6 completed, 2 unknown. 5 Phase 3, 2 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 4, Unknown 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow YM 529: new trials by email Literature Review of YM 529 trials Research Report on YM 529
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Minodronate in Patients With Low Back Pain Minodronate, Alendronate - Postmenopausal Osteoporosis | Phase 4 | Unknown | Peking University Third Hospital | 72 | 2023-01-01 | 2022-12-09 |
| A Phase III Clinical Study of Minodronate Tablets in Postmenopausal Women With Osteoporosis Minodronate Tablets and Alendronate Sodium Tablets-matching placebo;Alendronate Sodium Tablets and Minodronate Tablets -matching placebo - Osteoporosis | Phase 3 | Unknown | Shandong New Time Pharmaceutical Co., LTD | 330 | 2022-05-31 | 2022-03-31 |
| Pharmacokinetics and Tolerability of Minodronic Acid and Food and Age Effects on the Pharmacokinetics minodronic acid - Osteoporosis | Phase 1 | Completed | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 48 | 2014-08-01 | 2014-11-20 |
| A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulation ONO-5920 / YM529 - Osteoporosis, Osteoporosis, Postmenopausal | Phase 1 | Completed | Astellas Pharma Inc | 48 | 2009-07-01 | 2009-10-05 |
| ONO-5920/YM529 Confirmatory Study in Involutional Osteoporosis Patients YM529 / ONO-5920 - Osteoporosis, Bone Loss, Age-Related | Phase 2 / Phase 3 | Completed | Astellas Pharma Inc | 692 | 2008-11-01 | 2015-05-04 |
| Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan Minodronic acid hydrate - Involutional Osteoporosis | Phase 3 | Completed | Ono Pharmaceutical Co., Ltd. | 444 | 2004-06-01 | 2012-06-14 |
| Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan ONO-5920 - Involutional Osteoporosis | Phase 3 | Completed | Ono Pharmaceutical Co., Ltd. | 250 | 2003-05-01 | 2012-10-11 |
| Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan ONO-5920 - Involutional Osteoporosis | Phase 3 | Completed | Ono Pharmaceutical Co., Ltd. | 650 | 2002-08-01 | 2012-10-11 |
Osteoporosis (7) · Osteoporosis, Postmenopausal (2) · Bone Diseases (1) · Low Back Pain (1)
Ono Pharmaceutical Co., Ltd. (3) · Astellas Pharma Inc (2) · Peking University Third Hospital (1) · Shandong New Time Pharmaceutical Co., LTD (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)
Japan (3) · China (2)
Project Leader, Development Planning (2) · Chunli Song, Pro. (1) · Project Leader, ' Development Planning (1) · Toshiomi Minamide (1) · Weiyong Li, PhD (1)